3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 2
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Stomach Neoplasms
30
Carcinoma, Hepatocellular
22
Small Cell Lung Carcinoma
15
Colorectal Neoplasms
14
Carcinoma, Non-Small-Cell Lung
14
Sarcoma
13
Ovarian Neoplasms
12
Breast Neoplasms
12
Triple Negative Breast Neoplasms
9
Nasopharyngeal Carcinoma
9
Esophageal Squamous Cell Carcinoma
9
Cholangiocarcinoma
9
Biliary Tract Neoplasms
7
Squamous Cell Carcinoma of Head and Neck
6
Osteosarcoma
6
Lung Neoplasms
6
Pancreatic Neoplasms
5
Head and Neck Neoplasms
5
Esophageal Neoplasms
5
Uterine Cervical Neoplasms
4
Thyroid Neoplasms
4
Neoplasms
4
Melanoma
4
Solid Tumor
3
Recurrence
3
Neoplasm Metastasis
3
Liver Neoplasms
3
Glioma
3
Carcinoma, Adenoid Cystic
3
Advanced Gastric Cancer
3
Interventions
pembrolizumab
1
lenvatinib
1
apatinib
1
Pemetrexed
1
Paclitaxel
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Advanced Non-squamous Non-small-cell Lung Cancer
×
apatinib
×
Clear all
NCT03190239
2024-02-28
XQonc-007
Xinqiao Hospital of Chongqing
Phase 2
Withdrawn